Low dose systemic heparinization combined with heparin-coated extracorporeal circulation. Effects related to platelets

Journal of Cardiovascular Surgery

Volumn 42, Issue 5, 2001, Pages 579-585

  Mirow, N ^a   Brinkmann, T ^a   Minami, K ^a   Tenderich, G ^a   Schulte Eistrup, S ^a   Kleesiek, K ^a   Korfer R ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

Author keywords

Blood coagulation; Blood platelets; Cardiopulmonary bypass; Coated materials, biocompatible; Coronary artery bypass; Extracorporeal circulation; Heparin; Heparin, low molecular weight

Indexed keywords

AOTHEL; BETA THROMBOGLOBULIN; BREVYMITAL; ENFLURANE; FENTANYL; HEPARIN; LORMETAZEPAM; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; METHOHEXITAL; MORPHINE; ROCURONIUM; SUXAMETHONIUM;

ADULT; AGED; ARTICLE; BLOOD CLOTTING TIME; CARDIOPULMONARY BYPASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DRUG EFFECT; EXTRACORPOREAL CIRCULATION; HEPARINIZATION; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDY; PUMP; RANDOMIZED CONTROLLED TRIAL; SUCTION; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT;

ADULT; AGED; ANTICOAGULANTS; BLOOD COAGULATION; CARDIOPULMONARY BYPASS; CHI-SQUARE DISTRIBUTION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ARTERY BYPASS; FEMALE; FIBRINOLYSIS; HEPARIN; HUMANS; MALE; MIDDLE AGED; PLATELET ACTIVATION; POSTOPERATIVE HEMORRHAGE; PROSPECTIVE STUDIES;

EID: 0035160957     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Thrombosis and artificial surfaces
2. Cardiopulmonary bypass with heparin-coated circuits and reduced systemic anti-coagulation
3. Inhibition of platelet function by heparin. An etiologic factor in postbypass hemorrhage
4. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study
5. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits
6. Heparin-coated oxygenators significantly reduce contact system activation in an in vitro cardiopulmonary bypass model
7. Complement activation during cardiopulmonary bypass: Effects of immobilized heparin
8. Risk and benefit of low systemic heparinization during open heart operations
9. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: Clinical and hemostatic effects
10. Pathway of platelet protection in heparin-coated devices and its significance for cardiac surgery
11. Surface-bound heparin-panacea or peril?
12. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass
13. Low heparinization with heparin-bonded bypass circuits: Is it a safe strategy?
14. Heparinbeschichtung des extrakorporalen Kreislaufs: Gerinnungsaktivierung, Verbrauch und Fi-brinolyse in einer randomisierten Studie an Koronarbypasspatienten
15. Cardiopulmonary bypass with low systemic heparinization: An experimental study
16. Reduced blood loss and transfusion requirements with low systemic heparinization: Preliminary clinical results in coronary artery revascularization
17. Effect of anticoagulation protocol on outcome in patients undergoing CABG with heparin-bonded cardiopulmonary bypass circuits
18. Protamine induced hypotension in heart operations: Application of the concept of ventricular-arterial coupling
19. The heparin-protamine interaction
20. Fibrinogen heterogeneity
21. Loss of platelet fibrinogen receptors during clinical cardiopulmonary bypass
22. Postcardiopulmonary bypass bleeding: An introductory review
23. Effect of surface coating on platelet count drop during cardiopulmonary bypass
24. Mechanism of abnormal bleeding in patients undergoing cardiopulmonary bypass: Acquired transient platelet dysfunction associated with selective alpha-granule release
25. Blood platelets in cardiopulmonary bypass operations. Recovery occurs after initial stimulation, rather than continual activation
26. Quantitative evaluation of heparin-coated versus non-heparin-coated bypass circuits during cardiopulmonary bypass